Identifying advanced stage NSCLC patients who benefit from afatinib therapy using 18F-afatinib PET/CT imaging

Lung Cancer - Tập 155 - Trang 156-162 - 2021
Eveline A. van de Stadt1, Maqsood Yaqub2, Adriaan A. Lammertsma2, Alex J. Poot2, Robert C. Schuit2, Sharon Remmelzwaal3, Lothar A. Schwarte4, Egbert F. Smit1,5, Harry Hendrikse2,6, Idris Bahce1
1Department of Pulmonology, Amsterdam UMC location VUmc, Amsterdam, the Netherlands
2Department of Radiology and Nuclear Medicine, Amsterdam UMC, Location VUmc, Amsterdam, the Netherlands
3Department of Epidemiology and Data Science, Amsterdam UMC location VUmc, Amsterdam, the Netherlands
4Department of Anesthesiology, Amsterdam UMC location VUmc, Amsterdam, The Netherlands
5Department of Thoracic Oncology,Netherlands Cancer Institute, Amsterdam, The Netherlands
6Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, location VUMC, Amsterdam, The Netherlands

Thông tin
Thông tin xuất bản

Lung Cancer

Tập 155

156-162

Thông tin tác giả